F

Fresenius Medical Care

Operates dialysis facilities and renal care

International Commercial Marketing Lead

Full-TimeDeadline 11/1/26
No salary listed
Expert
Bachelor's, Master's
Madrid, Spain+1 moreMore locations: Chesterfield, UK
Hybrid
Growth & MarketingMarketing Generalist & Management

About the job

Requirements
  • Bachelor's or Master's degree in Business, Marketing, Economics, Finance, or a related field
  • 10+ years of strategic marketing experience within MedTech or healthcare
  • Fluent English communication skills; additional languages are an advantage
  • Proven success in commercial marketing, product launches, commercial excellence, segmentation, analytics, and product positioning, with expertise in developing data-driven targeting and growth strategies
  • Strong influencing and stakeholder management skills, with experience leveraging CRM and digital marketing tools to drive commercial performance, product portfolio optimization, and profitability
  • Strong understanding of omnichannel marketing, sales enablement, customer engagement, and the medical device environment, including regulatory requirements, reimbursement models, purchasing behaviors, claims limitations, and compliance expectations
  • Excellent analytical and strategic skills, with the ability to translate data, market insights, and financial performance into actionable commercial recommendations, and to lead through influence in complex global matrix organizations
  • Willingness to travel internationally and work across global time zones when required
Responsibilities
  • Develop segmentation and targeting strategies using customer insights and analytics
  • Optimize product mix to improve profitability across regions and customer segments
  • Use CRM data to track execution, measure impact, and drive commercial priorities
  • Create clinically credible and commercially effective customer-facing assets
  • Enable consistent omnichannel execution across digital, sales, distributors, and clinical education channels
  • Ensure messaging aligns with clinical evidence, product claims, and value propositions
  • Monitor campaign performance and implement continuous improvements
  • Lead and align global, regional, and country marketing teams
  • Promote best practice sharing and partner closely with regional sales leaders
  • Build, lead, and develop a high-performing global marketing team
  • Foster accountability, collaboration, innovation, and results-oriented execution
  • Lead the annual global marketing planning process with defined KPIs and priorities
  • Align local market plans with global strategy and ensure launch readiness
  • Track commercial performance and implement corrective actions when needed
  • Ensure compliance with company policies, SOPs, legal requirements, and the compliance framework

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...